George W. LeMaitre - Dec 2, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chairman and CEO, Director
Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Stock symbol
LMAT
Transactions as of
Dec 2, 2025
Transactions value $
-$38,074
Form type
4
Date filed
12/3/2025, 07:39 PM
Previous filing
Nov 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LeMaitre George W Chairman and CEO, Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Laurie A. Churchill, Attorney-in-fact 2025-12-03 0001365737

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +45 +0% $0.00 1.67M Dec 2, 2025 Direct F1
transaction LMAT Common Stock Tax liability -$38.1K -455 -0.03% $83.68 1.67M Dec 2, 2025 Direct F2
holding LMAT Common Stock 21.3K Dec 2, 2025 LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -45 -100% $0.00 0 Dec 2, 2025 Common Stock 45 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
F4 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.